FibroGen Inc (FGEN)
1.205
-0.04
(-2.82%)
USD |
NASDAQ |
May 17, 16:00
1.205
0.00 (0.00%)
After-Hours: 20:00
FibroGen Gross Profit (Quarterly): 30.15M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 30.15M |
December 31, 2023 | 21.73M |
September 30, 2023 | 35.89M |
June 30, 2023 | 38.61M |
March 31, 2023 | 32.67M |
December 31, 2022 | 29.44M |
September 30, 2022 | 11.43M |
June 30, 2022 | 23.00M |
March 31, 2022 | 56.59M |
December 31, 2021 | 13.42M |
September 30, 2021 | 152.71M |
June 30, 2021 | 21.29M |
Date | Value |
---|---|
March 31, 2021 | 35.03M |
December 31, 2020 | 62.38M |
September 30, 2020 | 41.82M |
June 30, 2020 | 39.81M |
March 31, 2020 | 23.43M |
December 31, 2019 | 7.069M |
September 30, 2019 | 32.93M |
June 30, 2019 | 191.57M |
March 31, 2019 | 23.86M |
December 31, 2018 | 108.06M |
September 30, 2018 | 29.03M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
7.069M
Minimum
Dec 2019
191.57M
Maximum
Jun 2019
45.05M
Average
32.80M
Median
Gross Profit (Quarterly) Benchmarks
Annovis Bio Inc | -- |
Emergent BioSolutions Inc | 147.80M |
Vertex Pharmaceuticals Inc | 2.348B |
Geron Corp | -- |
Nanoviricides Inc | -- |